# Treatment Study for Ischemic Optic Neuropathy With Opthalmic Timolol Maleate 0.5%

> **NCT01607671** · PHASE1 · WITHDRAWN · sponsor: **Fraser Health**

## Conditions studied

- Optic Neuropathy, Ischemic
- Anterior Ischemic Optic Neuropathy
- Ischemic Optic Neuropathy
- Optic Neuropathy, Anterior Ischemic

## Interventions

- **DRUG:** Timolol maleate

## Key facts

- **NCT ID:** NCT01607671
- **Lead sponsor:** Fraser Health
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-06
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Unable to recruit participants from recruiting sites.
- **Last updated:** 2015-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01607671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01607671, "Treatment Study for Ischemic Optic Neuropathy With Opthalmic Timolol Maleate 0.5%". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01607671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*